EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review

Sanya Thomas, Geoffrey Guenther, Jared H Rowe, Craig D Platt, Akiko Shimamura, Ofer Levy, Lakshmi Ganapathi

Frontiers in Pediatrics · 17.07.2023 · 11

DOI: 10.3389/fped.2023.1223191 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Pediatrics, online erschienen am 17.07.2023. Verfasst von Sanya Thomas und 6 weiteren Autor:innen. Beteiligte Einrichtung: Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe congenital neutropenia caused by jagunal homolog 1 ( JAGN1 ) mutation is a rare condition resulting from maturation arrest secondary to endoplasmic reticulum stress response from impaired neutrophil protein glycosylation. Here, we report a case of a 4-year-old boy who presented with a history of recurrent infections and manifestations, including recurrent intracranial hemorrhage. A review of similar cases reported in the literature indicates that a bleeding diathesis has not been previously described in these patients. We hypothesize that this newly described association of bleeding complications in this patient with JAGN1 mutation is secondary to defective glycosylation in the normal functioning of platelets or clotting factors. Recurrent infections with intracranial hemorrhage, new focal neurologic defects, or altered mental status in a child should warrant a suspicion for this immunodeficiency for the prompt initiation of treatment and prophylaxis for life-threatening infections or trauma.

Schlagwörter

Stichwörter der Autor:innen

JAGN1childrencongenitalneutropeniasevere congenital neutropenia (SCN)

Autor:innen und Institutionen

  • Precision Vaccines Program, Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States.
  • Harvard Medical School, Boston, MA, United States.
  • Division of Infectious Diseases, Boston Children's Hospital, Boston, MA, United States.
  • Division of Hematology, Boston Children's Hospital and Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.
  • Division of Immunology, Boston Children's Hospital, Boston, MA, United States.
  • Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.

Förderung

  • NIAID NIH HHS

Zitieren

APA

Thomas, S., Guenther, G., Rowe, J. H., Platt, C. D., Shimamura, A., Levy, O., & Ganapathi, L. (2023). Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. Frontiers in Pediatrics, 11. https://doi.org/10.3389/fped.2023.1223191

Vancouver

Thomas S, Guenther G, Rowe JH, Platt CD, Shimamura A, Levy O, et al. Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review. Frontiers in Pediatrics. 2023;11. doi:10.3389/fped.2023.1223191

BibTeX
@article{Thomas2023,
  author = {Thomas, Sanya and Guenther, Geoffrey and Rowe, Jared H and Platt, Craig D and Shimamura, Akiko and Levy, Ofer and Ganapathi, Lakshmi},
  title = {Severe congenital neutropenia due to jagunal homolog 1 (JAGN1) mutation: a case report and literature review},
  journal = {Frontiers in Pediatrics},
  year = {2023},
  volume = {11},
  doi = {10.3389/fped.2023.1223191}
}
Kostenlos starten →